Rufinamide Tablet, Film Coated
Product Images NDC 68462-714

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 68462-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl200mg120.jpg (Lbl200mg120)

Rufinamide Tablets, USP 200 mg film-coated tablets label from Glenmark Pharmaceuticals Inc., USA. The label includes the NDC 68462-713-08, states the package contains 120 tablets, and instructs pharmacists to dispense the Medication Guide separately. Storage information and manufacturer details are also shown.*

FDA Label Image

Lbl400mg120.jpg (Lbl400mg120)

Label for Rufinamide Tablets, USP 400 mg film-coated oral tablets. Contains 120 tablets per bottle. Label includes storage instructions, barcode, and manufacturer Glenmark Pharmaceuticals Inc., USA. The label notes that the medication guide must be dispensed separately to the patient.*

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure.jpg (Structure)

Chemical structure of rufinamide, showing its molecular formula with fluorinated aromatic ring linked to a triazole carboxamide moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.